YD Bio Reports 12-Cent Loss Per Share for 2025
YDES is trading near its 52-week low of $5 (2.0% above the low).
Summary
YD Bio Ltd. announced a loss per share of 12 cents for the 2025 fiscal year. This direct financial result indicates continued unprofitability for the company. For a company currently trading near its 52-week low, reporting a loss can further pressure the stock as it highlights ongoing operational challenges. Traders will be closely watching for further details on the company's financial health and any outlook provided for future periods.
At the time of this announcement, YDES was trading at $5.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $359.7M. The 52-week trading range was $5.00 to $31.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.